26.40 USD
↗ 1.37 (5.47%)AT CLOSE (11:59 AM EDT)
Alumis Inc. Common Stock
ALMSNASDAQ • USD
26.37
↘ 0.03 (0.10%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
26.37
↘ 0.03 (0.10%)
Market: CLOSED
Shares of Alumis Inc. Common Stock (ALMS) are trading at $26.40. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$25.01
High?$26.50
Low?$24.71
Prev. Close?$25.03
Volume?6.2M
Avg. Volume?1.4M
VWAP?$25.74
Rel. Volume?4.56x
Bid / Ask
Bid?$21.07 × 100
Ask?$30.75 × 100
Spread?$9.68
Midpoint?$25.91
Valuation & Ratios
Market Cap?3.4B
Shares Out?123.4M
Float?71.1M
Float %?57.7%
P/E Ratio?N/A
P/B Ratio?5.94
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Themes
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?27
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?15.86Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?17.81%High
Short Interest?12.7M
Days to Cover?8.7
Free Float71.1M
Avg Daily Volume1.5M
Settlement Date2026-06-15
Financial Health
Current Ratio?7.51Strong
Quick Ratio?7.51Strong
Cash Ratio?0.90Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.94FAIR▾
Peers100
S&P31
P/S?400.59HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.4CHEAP▾
S&P97
EV/Sales?392.99HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-41.9%WEAK▾
S&P3
ROA?-35.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-377030000
Enterprise Value?$3.3B
Fundamentals ratios updated end of day